{
    "Relevant Biomarkers": [
        {
            "BioMarker": "MYO1G",
            "Method": "Seq",
            "Analyte": "RNA-Tumor",
            "Result": "Stable"
        },
        {
            "BioMarker": "PDGFRA",
            "Method": "Seq",
            "Analyte": "DNA-Tumor",
            "Result": "Mutation not detected"
        },
        {
            "BioMarker": "PR",
            "Method": "IHC",
            "Analyte": "Protien",
            "Result": "Positive| 2+, 88%"
        },
        {
            "BioMarker": "DPYD",
            "Method": "Seq",
            "Analyte": "RNA-Tumor",
            "Result": "Mutation not detected"
        },
        {
            "BioMarker": "PD-L1(SP142)",
            "Method": "IHC",
            "Analyte": "Protien",
            "Result": "Negative| 1+, 70%"
        },
        {
            "BioMarker": "TP53",
            "Method": "Seq",
            "Analyte": "DNA-Tumor",
            "Result": "Stable"
        },
        {
            "BioMarker": "AR",
            "Method": "IHC",
            "Analyte": "Protien",
            "Result": "Negative| 3+, 57%"
        },
        {
            "BioMarker": "CDC73",
            "Method": "Seq",
            "Analyte": "DNA-Tumor",
            "Result": "Mutation not detected"
        }
    ],
    "Genomic Signatures": [
        {
            "BioMarker": "Microsatellite instability",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Result": "High"
        },
        {
            "BioMarker": "Tumor mutational burden",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Result": "12 mutations/Mb Low"
        },
        {
            "BioMarker": "Genomic loss of heterozygosity (LOH)",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Result": "High - 18% of tested genmoic segments exhibit LOH"
        }
    ],
    "Genes Tested with Pathogenic Alterations": [
        {
            "Gene": "ABL1",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Pathogenic",
            "Protien Alteration": "p.R130G",
            "Exon": 18,
            "DNA Alteration": "c.545T>G",
            "Allele Frequency %": "35.59"
        },
        {
            "Gene": "CDKN2A",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Likely Benign",
            "Protien Alteration": "p.R1012X",
            "Exon": 14,
            "DNA Alteration": ".",
            "Allele Frequency %": "17.72"
        },
        {
            "Gene": "KLF4",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Likely Pathogenic",
            "Protien Alteration": "p.L239R",
            "Exon": 2,
            "DNA Alteration": "c.716T>G",
            "Allele Frequency %": "12.63"
        },
        {
            "Gene": "FGFR1",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Likely Pathogenic",
            "Protien Alteration": "p.G503A",
            "Exon": 4,
            "DNA Alteration": "c.1508G>C",
            "Allele Frequency %": "4.16"
        },
        {
            "Gene": "SF3B1",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Benign",
            "Protien Alteration": "p.H362R",
            "Exon": 12,
            "DNA Alteration": "c.1085A>G",
            "Allele Frequency %": "6.17"
        },
        {
            "Gene": "SDHD",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Likely Pathogenic",
            "Protien Alteration": "p.N452D",
            "Exon": 18,
            "DNA Alteration": "c.1354A>G",
            "Allele Frequency %": "2.53"
        }
    ]
}